Healthcare Cyberattacks Grew in 2022. How Should the Industry Combat Them?

Concerning data from cybersecurity firm Check Point indicates an increase in cyberattacks on healthcare organizations by 74% in 2022 from the previous year.

Healthcare is currently the third most attacked global industry (1,463 attacks per week) behind government/military (1,661 attacks per week) and education/research (2,314 attacks per week.) And in the United States, Healthcare ranks second in weekly attacks.

For example, with the growth of AI-driven technology, researchers and other security professionals worry hackers may use tools like ChatGPT to create phishing emails and launch other sophisticated cyberattacks.

One piece of potential good news for those working to protect healthcare institutions from cyberattacks is the recent passage of the bi-partisan PATCH Act, introduced by U.S. Senators Bill Cassidy, M.D. (R-LA) and Tammy Baldwin (D-WI) to provide much-needed security and safety measure for healthcare system’s cyber infrastructure. The PATCH Act effort was successfully included in the December 2022 Omnibus Appropriations bill – and is now law of the land.

An expert in cybersecurity and VP of Cyber Safety Strategy for Claroty, Joshua Corman, weighed in on the rise of cyberattacks in healthcare and the efforts to combat them.

Joshua’s Thoughts

“For me, the passage of the PATCH Act has been at least a nine-year journey trying to argue that connected medical technologies need minimum cyber hygiene, just like cars needed seat belts and safety features. So it’s been building trust with the US Food and Drug Administration, helping inform their pre- and post-market guidance, but not backed by statute. There was a 2015 congressional task force for healthcare industry cybersecurity I served on, and ultimately during the pandemic under record-high ransomware attacks as well, we saw that disruption to healthcare tech from accidents and adversaries can precipitate loss of life. This was overdue and now we have it backed by law.

How can it help hospitals? Hospitals have a shared responsibility, both with how defensible and resilient the technology we procure and deploy is, to begin with, so our supply chain of medical devices and medical technologies, plus how well we secure them. Any hospital regardless of size or funding will now benefit from at least minimum cyber hygiene for the devices we procure and deploy, so we have a fighting chance of keeping them free from accidents and adversaries.

And why now? I think I would’ve preferred this nine years ago, but there has been growing recognition that we were prone, we were prey, and we just lacked predator interest. Over the last three years with record-high attacks on healthcare from ransomware and brazen criminal actors, degraded and delayed care affects patient outcomes and even mortality rates, and these protracted ransom attacks have been documented in part by my team at CISA to introduce delays sufficient to lead to loss of life. Congress has taken notice. The White House has taken notice, and there is finally political will to step up here and preserve the trust of the public in this technology.”

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More